Esteban, JI; Viladomiu, L; Bonzalez, A; Roget, M; Genesca, J; Guardia, J; Esteban, R; Lopez-Talavera, JC; Hernandez, JM; Vargas, V; Buti, M; Kuo, G; Choo, Q-L; Houghton, M (1989). «Hepatitis C virus antibodies among risk groups in Spain». Lancet. 334 (8658): 294–297. doi:10.1016/s0140-6736(89)90485-6. PMID2569102. S2CID23825621.
Van Der Poel, CL; Ressink, HW; Lelie, PN; Leentvaar-Kuypers, A; Choo, Q-L; Kuo, G; Houghton, M (1989). «Anti-hepatitis C antibodies and non-A, non-B post-transfusion hepatitis in the Netherlands». Lancet. 334 (8658): 297–298. doi:10.1016/s0140-6736(89)90486-8. PMID2569103. S2CID25211687.
Esteban, JI; Viladomiu, L; Bonzalez, A; Roget, M; Genesca, J; Guardia, J; Esteban, R; Lopez-Talavera, JC; Hernandez, JM; Vargas, V; Buti, M; Kuo, G; Choo, Q-L; Houghton, M (1989). «Hepatitis C virus antibodies among risk groups in Spain». Lancet. 334 (8658): 294–297. doi:10.1016/s0140-6736(89)90485-6. PMID2569102. S2CID23825621.
Van Der Poel, CL; Ressink, HW; Lelie, PN; Leentvaar-Kuypers, A; Choo, Q-L; Kuo, G; Houghton, M (1989). «Anti-hepatitis C antibodies and non-A, non-B post-transfusion hepatitis in the Netherlands». Lancet. 334 (8658): 297–298. doi:10.1016/s0140-6736(89)90486-8. PMID2569103. S2CID25211687.
Esteban, JI; Viladomiu, L; Bonzalez, A; Roget, M; Genesca, J; Guardia, J; Esteban, R; Lopez-Talavera, JC; Hernandez, JM; Vargas, V; Buti, M; Kuo, G; Choo, Q-L; Houghton, M (1989). «Hepatitis C virus antibodies among risk groups in Spain». Lancet. 334 (8658): 294–297. doi:10.1016/s0140-6736(89)90485-6. PMID2569102. S2CID23825621.
Van Der Poel, CL; Ressink, HW; Lelie, PN; Leentvaar-Kuypers, A; Choo, Q-L; Kuo, G; Houghton, M (1989). «Anti-hepatitis C antibodies and non-A, non-B post-transfusion hepatitis in the Netherlands». Lancet. 334 (8658): 297–298. doi:10.1016/s0140-6736(89)90486-8. PMID2569103. S2CID25211687.
Bresters, D; Cuypers, HT; Reesink, HW; Schaasberg, WP; van der Poel, CL; Mauser-Bunschoten, EP; Houghton, M; Choo, Q-L; Kuo, G; Lesniewski, R; Troonen, H; Lelie, PN (1992). «Enhanced sensitivity of a second generation ELISA for antibody to hepatitis C virus». Vox Sang. 62 (4): 213–217. doi:10.1111/j.1423-0410.1992.tb01201.x. PMID1379394. S2CID20178902.